Skip to main content

Table 2 Summary table showing the socio-demographic characteristics, catatonia symptoms, LZP dosage and outcome of the sampled NS children

From: Catatonia in Ugandan children with nodding syndrome and effects of treatment with lorazepam: a pilot study

Child ID Age (years) BMI WHO-BMI Classification School attendance Case classification Current drug treatment Catatonia symptoms before treatment Initial catatonia score Initial dose of LZP (mg) Score 60′ after first dose Repeat dose of LZP Score 60′ after second dose Outcome Side effects
CT001 15 16.44 Moderate thinness Never Head nodding syndrome plus Sodium valproate 2, 3, 4, 5, 9 17 1 4 None   Improved None
CT002 18 18.66 Underweight Dropped out P.4 Head nodding syndrome Sodium valproate 2, 3, 4, 7, 9 19 1 9 None   Improved Sedation
Seizure (fell down)
CT003 15 15.98 Severe thinness Never Head nodding syndrome plus Sodium valproate 1, 3, 4, 5, 7, 8, 10 22 1 2 None   Improved None
CT004 15 12.55 Severe thinness Dropped out P.3 Head nodding syndrome plus Sodium valproate 2, 3, 4, 5, 9 17 0.5 10 None   Improved Focal seizure with automatisms
CT005 14 14.81 Severe thinness Never Head nodding syndrome plus Sodium valproate 2, 3, 4, 5, 7, 8, 9 24 1 24 2 mg 4 Improved None
CT006 13 15.18 Severe thinness Dropped out P.3 Head nodding syndrome Carbama-zepine 1, 2, 3, 4, 9 15 1 15 2 mg 15 No improvement Sedation
CT007 10 13.48 Severe thinness In school in P.1 Head nodding syndrome Carbama-zepine 3, 4, 5 10 0.5 10 1 mg 1 Improved None
CT008 10 12.07 Severe thinness Never Head nodding syndrome plus Sodium valproate 2, 3, 4, 5, 8, 9 17 0.5 6 None   Improved None
CT009 14 20.48 Normal Dropped out P.1 Head nodding syndrome plus Sodium valproate 2, 4, 5, 9 8 1 8 2 mg 14 No improvement
Nodding episode seen
Sedation
Seizure (fell down)
CT010 15 18.65 Normal In school in P.3, demoted from P.6 Head nodding syndrome Sodium valproate 2, 3, 4, 7, 9 12 1 12 2 mg 12 No improvement Sedation
CT011 16 17.5 Mild thinness Never Head nodding syndrome plus Carbama-zepine 1, 3, 4, 5, 8, 9, 10 27 1 27 2 mg 9 Improved Sedation
CT012 19 15.06 Severe thinness Dropped out P.1 Head nodding syndrome plus Sodium valproate 2, 3, 4, 5, 7, 9 20 1 12 None   Improved Sedation
CT013 18 13.43 Severe thinness Never Head nodding syndrome plus Sodium valproate 2, 3, 4, 5, 7, 8, 9 25 0.5 9 None   Improved Sedation
CT014 13 10.36 Severe thinness Never Head nodding syndrome plus Carbama-zepine 2, 3, 4, 5, 7, 9 20 0.5 12 None   Improved Sedation
CT015 21 16.3 Moderate thinness Dropped out P.1 Head nodding syndrome plus Carbama-zepine 1, 2, 3, 4, 7, 9, 10 27 1 13 None   Improved Drooling saliva
CT016 15 14.1 Severe thinness Dropped out P.2 Head nodding syndrome plus Carbama-zepine 1, 2, 3, 4, 5, 7, 9 18 1 7 None   Improved None
Key for the catatonia symptoms
Number Symptom
1 Excitement
2 Immobility-stupor
3 Mutism
4 Staring
5 Grimacing
6 Echopraxia or echolalia
7 Rigidity
8 Negativism
9 Active or passive refusal to eat or drink
10 Impulsivity